Quantcast

Latest Cystic Fibrosis Foundation Stories

2014-09-16 08:29:49

Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis DURHAM, N.C., Sept. 16, 2014 /PRNewswire-USNewswire/ -- Parion Sciences today announced it has received a $3 million award from Cystic Fibrosis Foundation Therapeutics (CFFT) to support the development of P-1037, Parion's new investigational treatment for cystic fibrosis (CF). This award will accelerate the initiation of a phase 2 trial for P-1037...

2014-09-10 08:22:49

Cystic Fibrosis Foundation - Greater Illinois Chapter wins August's Community Assistance Program LINCOLNWOOD, Ill., Sept. 10, 2014 /PRNewswire-iReach/ -- Through a monthly social media initiative, Loeber Motors recently named the Cystic Fibrosis Foundation - Greater Illinois Chapter the winner of a $500 donation on behalf of the dealership. Photo - http://photos.prnewswire.com/prnh/20140910/144890 The monthly campaign, or Community Assistance Program, is a crusade to raise...

2014-08-27 23:05:57

Top South Florida nutrition and health supplement company IQ Formulations today announced its latest contribution to the Cystic Fibrosis Foundation through a generous donation including five percent of an entire month’s product proceeds. A company recently named to the Inc. 500 and dedicated to raising standards within its industry, IQ Formulations makes giving back to its local community and deserving organizations a top priority. Sunrise, FL (PRWEB) August 27, 2014 IQ Formulations, a...

2014-07-24 23:12:56

80s cover band Flashback Heart Attack topped last year's performance at the Cystic Fibrosis Foundation annual charity event by breaking out the rock stars Saturday night. The night set record numbers on attendance and net a profit for Pipeline to a Cure and the Cystic Fibrosis Foundation. Huntington Beach, CA (PRWEB) July 24, 2014 The event, called Pipeline to a Cure, took place Saturday July 19, 2014 at the Hyatt Regency in Huntington Beach, Calif. The evening, coming off the buzz...

2014-07-14 16:24:30

Anthera to Form a New Subsidiary, Alkira Therapeutics, to Assume All Development Activities and Registration Activities as a Subsidiary of Anthera HAYWARD, Calif., July 14, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme Replacement Therapy ("PERT") from Eli Lilly and Company. Sollpura is a soluble, stable and non-porcine enzyme product intended for the treatment...

2014-06-30 08:30:32

SOUTH PLAINFIELD, N.J., June 30, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the initiation of a global confirmatory Phase 3 clinical trial of Translarna(TM) (ataluren), an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF). Nonsense mutations within cystic fibrosis are categorized as Class I mutations, a severe form of CF that results in little or no production of the CFTR protein. The Phase 3 confirmatory trial is...

2014-06-24 23:15:51

From a Babe Ruth signed baseball, Muhammad Ali signed Boxing Gloves, a 1937 Slot Machine, a flight in a Jet Fighter, or tickets to a sport’s or red carpet event, silent and live auctions contribute greatly to maximize profits for charities – all while helping the world’s most vulnerable people and causes. Tampa, FL (PRWEB) June 24, 2014 From a Babe Ruth signed baseball, Muhammad Ali signed Boxing Gloves, a 1937 Slot Machine, a flight in a Jet Fighter, or tickets to a sport’s or...

2014-06-24 12:27:59

CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process BETHESDA, Md., June 24, 2014 /PRNewswire-USNewswire/ -- The Cystic Fibrosis Foundation applauds the successful results of Phase 3 studies of ivacaftor (Kalydeco(TM)) in combination with lumacaftor (VX-809) for people with two copies of the F508del mutation of cystic fibrosis (CF). The results showed significant improvements in lung function and other key measures of the disease,...

2014-06-02 08:31:12

Staff expanded in preparation for initiation of pulmonary and ophthalmic clinical trials DURHAM, N.C., June 2, 2014 /PRNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, today announced senior leadership and organizational changes. The changes include the following: -- Paul Boucher has been promoted to President and will lead the executive management team, business development and provide overall...

2014-05-26 12:21:59

LONDON, May 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growthhttp://www.reportbuyer.com/pharma_healthcare/diseases/cystic_fibrosis_therapeutics_major_developed_markets_2019_cftr_modulators_initiate_drive_towards_personalized_treatment_market_growth.htmlCystic Fibrosis Therapeutics in Major Developed Markets...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'